Global Brain Monitoring Market is projected to grow at a decent rate of 6-7% by 2026 - Increasing Applications of Brain Monitoring in Clinical Trials

Brain monitoring is defined as clinical neurological, neurophysiological, neuroradiological, ultrasound-based, and invasive monitoring of a patient's nervous system. Brain monitoring aims to detect altered or pathological neurological function as quickly as possible so that the correct treatment can be administered before irreversible damage occurs.

Growing Demand for Non-Invasive Brain Monitoring Techniques for Measuring Intracranial Pressure Drives the Global Brain Monitoring Market

Non-invasive monitoring methods provide a reliable alternative to invasive methods. Several techniques are available such as ICP monitors, transcranial doppler, electroencephalogram, near-infrared spectroscopy, etc which can be used in several conditions. Citing the growing demand for non-invasive techniques, several players have launched innovative products which are expected to propel the market in the coming years. For instance,

 In September 2021, NeuroWave Systems Inc. announced the FDA clearance of its NeuroSENSE® NS-901 Monitor.
 In August 2020, IRRAS AB announced the first patient treatment using the Hummingbird Solo.

Increase in Application of Electroencephalogram (EEG) for Diagnosing Neurological Disorder Propels the Brain Monitoring Market Growth

An EEG is a test that detects abnormalities in brain waves or the brain's electrical activity. The EEG is used to evaluate several types of brain disorders such as monitoring blood flow in the brain during surgical procedures determine the overall electrical activity of the brain, Alzheimer's disease, certain psychosis, and a sleep disorder called narcolepsy, epilepsy, etc.

Potential of Brain Monitoring Using Sensors, Wearables, and Mobile Devices Boosts the Brain Monitoring Market Demand

Rapid technological developments have been witnessed in the area of portable EEG monitoring, sleep assessment, gait analysis, cognitive function testing, eye tracking, and voice analysis. For instance:
 Interaxon Inc. launched the second generation of its popular EEG meditation & sleep headband, Muse S.
 NeuroSky developed ZenZone's apps designed to receive feedback data from the body via a sensor, which helps the app understand the state of mind and body.

Growing Adoption of Brain Multimodality Monitoring in Neurocritical Care of Comatose Patients Fuels the Global Market

Neurocritical care patients are at risk of developing secondary brain injury. Multimodality monitoring (MMM) encompasses various tools to monitor cerebral metabolism, perfusion, and oxygenation aimed at detecting these changes to help modify therapies before irreversible injury sets in.

Key Market Challenges: Brain Monitoring Market

High costs associated with the complex brain monitoring procedures and devices, unfavorable reimbursement policies, and a shortage of trained professionals are some of the key factors that are likely to hamper the growth of the brain monitoring market.

North America Holds the Largest Share in the Brain Monitoring Market

North America holds the major share in the brain monitoring market. This can be mainly attributed to the adoption of technologically advanced brain monitoring devices, increasing awareness regarding neurodegenerative disorders, and growing applications in clinical trials in this regions.

Competitive Landscape Analysis: Global Brain Monitoring Market

Some of the established market players operating in the global brain monitoring market are Natus Medical Inc., Nihon Kohden Corporation, Philips Healthcare, and Siemens Healthineers, among others.

Organic and Inorganic Growth Strategies Adopted by Players to Establish Their Foothold in the Brain Monitoring Market

Leading players operating in the global brain monitoring market are adopting both organic and inorganic growth strategies such as collaborations, acquisitions, and new product launches to garner a higher market share. For instance,

 In July 2022, Philips announced that they have received U.S. Food and Drug Administration (FDA) 510(k) clearance for their SmartSpeed artificial intelligence (AI) powered MR acceleration software.
 In October 2021, Brain Scientific announced that they have received FDA Clearance for Next-Gen NeuroCap EEG Headset, an advanced Electroencephalogram (EEG) electrode array.

Get Detailed Insights on Brain Monitoring Market with Report TOC & Sample Deliverables @ https://meditechinsights.com/global-brain-monitoring-market/

Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com
https://meditechinsights.com/

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

This release was published on openPR.